Please login to the form below

Not currently logged in

icosapent ethyl

This page shows the latest icosapent ethyl news and features for those working in and with pharma, biotech and healthcare.

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

Vascepa (icosapent ethyl) is already approved to treat elevated triglycerides, a risk factor for heart disease, but could see its usage rise markedly if it also gets the new cardiovascular risk ... The highly purified version of the omega-3 acid commonly

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
Its Know Your Numbers week
Do you know yours?...